🇺🇸 FDA
Pipeline program

ASTX660

CCR5199

Phase 1 small_molecule active

Quick answer

ASTX660 for Advanced Cancer is a Phase 1 program (small_molecule) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
UNITED THERAPEUTICS Corp
Indication
Advanced Cancer
Phase
Phase 1
Modality
small_molecule
Status
active

Clinical trials